A biannual report on vaccine administration shows reported errors by practitioners continued to trend up in the years following the COVID-19 pandemic.

The schedules incorporate policies approved over the past year and tweaks to improve clarity and readability. They have been endorsed by the AAP.

The CDC advisers also discussed a new RSV immunization on the horizon for infants.

Read about the latest developments in COVID-19 vaccines and therapeutics. Plus, AAP guidance to protect children during the pandemic.

Just 54% of children and adolescents were vaccinated against flu last season while about 14% got an updated COVID-19 vaccine.

Children are not immune from severe COVID-19 disease. Everyone 6 months and older should get a 2024-'25 season COVID-19 vaccine.

Novavax's COVID-19 vaccine targets the omicron JN.1 strain of SARS-CoV-2 and can be used for people 12 years and older.

The mRNA vaccines from Moderna and Pfizer-BioNTech are monovalent vaccines that better match circulating strains.

Updated vaccines are awaiting final regulatory approval, which could come in the next few weeks. The vaccines have been updated to better match circulating strains of SARS-CoV-2.

Wastewater testing by the Centers for Disease Control and Prevention (CDC) indicates COVID levels are very high nationally and especially in the West and South.

The study compared measures of career satisfaction and well-being between female and male pediatricians before and during the COVID-19 pandemic.

About 234,000 children under age 18 were hospitalized with confirmed cases of COVID-19 from fall 2020 to spring 2024.

The COVID-19 pandemic emphasized how inequities based on race and socioeconomic status impact the risk of infection and infection-related outcomes in children.

While it typically takes six to 10 years for a drug approved for adults to receive pediatric labeling, remdesivir was approved for use in pediatric patients, including neonates, about three years after approval for use in adults and adolescents.

A federal vaccine advisory committee is recommending everyone 6 months of age and older be vaccinated against COVID-19 and influenza ahead of the 2024-'25 respiratory virus season.

The AAP clinical report Supporting the Grieving Child and Family has been updated with new content on the unique characteristics of bereavement due to the COVID-19 pandemic, as well as the extra challenges faced by grieving children in minority or otherwise marginalized or disadvantaged communities.

Experts voted 16-0 in favor of updating the COVID-19 vaccines to better match circulating virus strains.

Parental hesitancy and missed well-child visits were barriers to timely vaccination, according to an AAP Periodic Survey.

The AAP remains focused on the child and adolescent mental health crisis, continuing academic and social challenges, pediatric workforce hardships and families’ loss of health insurance and income.

Studies covered SSRI prescribing, mental health hospital visits, long COVID, youth homelessness and inequalities in patient-centered medical homes.